HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aleksandra Rizo Selected Research

imetelstat

7/2022Imetelstat in intermediate-2 or high-risk myelofibrosis refractory to JAK inhibitor: IMpactMF phase III study design.
1/2022Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data.
10/2021Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis.
1/2021Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aleksandra Rizo Research Topics

Disease

3Primary Myelofibrosis (Myelosclerosis)
07/2022 - 10/2021
2Neoplasms (Cancer)
01/2022 - 11/2010
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2021
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2016
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2015
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2007

Drug/Important Bio-Agent (IBA)

4imetelstatIBA
07/2022 - 01/2021
2Janus Kinase InhibitorsIBA
07/2022 - 01/2022
2Telomerase (Telomerase Reverse Transcriptase)IBA
07/2022 - 10/2021
2Rituximab (Mabthera)FDA Link
02/2016 - 10/2015
1Janus KinasesIBA
01/2022
1ruxolitinibIBA
01/2022
1Phosphotransferases (Kinase)IBA
10/2021
1Biomarkers (Surrogate Marker)IBA
10/2021
1HematinicsIBA
01/2021
1temsirolimusFDA Link
02/2016
1ibrutinibIBA
02/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2015
1Prednisone (Sone)FDA LinkGeneric
10/2015
1Vincristine (Oncovin)FDA LinkGeneric
10/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2015
1Bortezomib (Velcade)FDA Link
10/2015
1N 30IBA
10/2007

Therapy/Procedure

4Therapeutics
01/2022 - 11/2010